(Medical Xpress)—In chaos theory – the study of dynamical systems highly sensitive to initial conditions – was first described in 1890 by Henri Poincaré1, followed by work by Jacques Hadamard in 1898 and Pierre Duhem ...
Scientists from the Johns Hopkins Kimmel Cancer Center have created a statistical model that measures the proportion of cancer incidence, across many tissue types, caused mainly by random mutations that occur when stem cells ...
Jan 1, 2015
28
1
Scientists often test drugs in mice. Now some cancer patients are doing the same—with the hope of curing their own disease.
Dec 14, 2014
0
0
Scientists at Dana-Farber Cancer Institute, the Massachusetts Institute of Technology, and other institutions have discovered a sign of the early development of pancreatic cancer – an upsurge in certain amino acids that ...
Sep 28, 2014
0
0
(Medical Xpress)—Research from Columbia University Medical Center shows that nerves may play a critical role in stomach cancer growth and that blocking nerve signals using surgery or Botox (onabotulinumtoxinA) could be ...
Aug 20, 2014
0
62
A modified version of the Clostridium novyi (C. noyvi-NT) bacterium can produce a strong and precisely targeted anti-tumor response in rats, dogs and now humans, according to a new report from Johns Hopkins Kimmel Cancer ...
Aug 13, 2014
3
0
Just over two years ago, Melinda Bachini decided she was done with chemotherapy to treat her cholangiocarcinoma—a rare cancer of the bile duct that runs from the liver to the intestines.
May 8, 2014
0
1
(Medical Xpress)—The BRCA1 gene, known for its role in suppressing the growth of breast and ovarian tumors, could be necessary for brain development. In a study appearing in the Proceedings of the National Academy of Sciences, ...
(Medical Xpress)—Aspirin and resveratrol kill tetraploid cells in mice and humans, according to a study by Guido Kroemer of the Gustave Roussy Institute in Villejuif, France and his colleagues. Precancerous lesions often ...
Analyzing the genomes of twin 3-year-old sisters – one healthy and one with aggressive leukemia – led an international team of researchers to identify a novel molecular target that could become a way to treat recurring ...
Feb 9, 2014
0
0
